Loading

logo

Journal of Physical Medicine and Rehabilitation

ISSN: 2690-0297

Research Article Open Access
Volume 4 | Issue 1 | DOI: https://doi.org/10.33696/rehabilitation.4.026

Comparative Effect of Levetiracetam and Carbamazepine versus Levetiracetam and Sodium Valproate on Seizure Frequency in Patients with Epilepsy

Surena Nazarbaghi1, *, Hamid Hosseinpour2, Samaneh Mirzaie3, Tella Sadighpour4
  • 1Department of Neurology, Imam Khomeini Hospital, Urmia University of Medical Sciences, Urmia, Iran
  • 2Neurosurgery Department, Urmia University of Medical Sciences, Urmia, Iran
  • 3Medical Doctor, Urmia University of Medical Sciences, Urmia, Iran
  • 4Herbert Wertheim College of Medicine, Florida International University, Florida, USA and American University of Antigua College of Medicine, Antigua and Barbuda
+ Affiliations - Affiliations

Corresponding Author

Surena Nazarbaghi, ena.nazarbaghi@gmail.com; nazarbaghi_s@umsu.ac.ir

Received Date: March 15, 2022

Accepted Date: April 25, 2022

Citation:

Nazarbaghi S, Hosseinpour H, Mirzaie S, Sadighpour T. Comparative Effect of Levetiracetam and Carbamazepine versus Levetiracetam and Sodium Valproate on Seizure Frequency in Patients with Epilepsy. J Phys Med Rehabil. 2022;4(1):13-18.


Copyright: © 2022 Nazarbaghi S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Introduction: One of the drugs that are added to common treatments in drug-resistant epilepsy is levetiracetam. Objectives: In this study, the effect of levetiracetam and carbamazepine with levetiracetam and sodium valproate on seizure frequency in patients with epilepsy was compared.

Patients and Methods: This study was a clinical trial in which pre-treatment and post-treatment seizures were compared. In this study, 180 patients with generalized seizures (primary or secondary) who were treated with carbamazepine or sodium valproate were included. The patients were divided into two groups based on receiving the drug carbamazepine (group A) and sodium valproate (group B), and they were examined in periods of 4, 8, 12 and 24 weeks after treatment.

Results: The results of the study showed that in the group treated with carbamazepine and levothyrostam, 40% of patients reported drowsiness, but in the group treated with sodium valproate and levetiracetam this rate was lower and 28% of patients reported that patients better tolerate sodium valproate and levetiracetam. Regarding the frequency of seizure, the treated group with carbamazepine and levothyrostam had better results than the treated group with sodium valproate and levetiracetam, although this difference was not significant (P>0.05).

Conclusion: The addition of levetiracetam to the treatment of patients with carbamazepine and sodium valproate had good results and was well tolerated by patients and did not cause any serious side effects in any treatment group.

Keywords

Levetiracetam, Carbamazepine, Sodium valproate, Epilepsy, Seizure.

Recommended Articles

Comparative Effect of Levetiracetam and Carbamazepine versus Levetiracetam and Sodium Valproate on Seizure Frequency in Patients with Epilepsy

Epilepsy involves one or a group of chronic disorders in which seizures recur unprovoked and unpredicted. Epidemiological studies in the United States estimate that about 2 million people have epilepsy. About 44 cases per 100,000 people annually are diagnosed with epilepsy, which is about 1% in the United States at the age of about

Epilepsy in Neurodegenerative Disease: A Commentary

Case Summary - We published a case report of a 22-year-old woman who presented to our university hospital with encephalopathy and left hemiparesis of a few weeks duration. 

To Stick or Not to Stick? Scalp and Intracranial EEG Evaluation Both Help Achieve Good Surgical and Neuropsychiatric Outcomes in Epilepsy Surgery up to 20 Years Post-Surgery

Epilepsy has a worldwide prevalence of about 50 million [1]. Seizure medications provide adequate control in two thirds of these patients but about a third are refractory to multiple medications and need surgery or other treatments [2].

Responsive Neurostimulation for Management of Refractory Precuneus Onset Epilepsy: A Case Report

Posterior quadrant epilepsy is relatively uncommon and refractory seizures from these regions are difficult to diagnose and manage. A 28-year-old woman presented for evaluation of her seizures. Scalp Electroencephalogram (EEG) showed seizures with independent onset over the right posterior and left anterior regions.

Homeostatic Synaptic Plasticity may be Targeted for the Prevention of Post-Stroke Epilepsy

Stroke is the most common cause of acquired epilepsy, with up to 30 percent of stroke survivors developing epilepsy over time. However, the mechanisms leading to neuronal hyperexcitability and epilepsy in stroke survivors are not fully understood. In a recently published work, we demonstrate that ischemic stroke induces homeostatic plasticity regulation in the surviving neurons in the peri-stroke area.

Full Text
Cite
Download PDF
Author Information X

About Scientific Archives

Scientific Archives is a global publisher initiated with the mission of ensuring equal opportunity for accessing science to research community all over the world. Spreading research findings with great relevance to all channels without any barrier is our goal. We want to overcome the challenges of Open Access with ensured quality and transparency.

Read More